Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Naumnik, B.
Right arrow Articles by Mysliwiec, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naumnik, B.
Right arrow Articles by Mysliwiec, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 526-528
© 2002 European Renal Association-European Dialysis and Transplant Association

Letters

Renal function, proteinuria and ACE-inhibitor therapy as determinants of plasma levels of endothelial markers

Beata Naumnik, Jacek Borawski, Krystyna Pawlak and Michal Mysliwiec

Department of Nephrology and Internal Medicine Medical Academy Bialystok, Poland

Sir,

Dysfunction of vascular endothelial cells (ECs) is of growing importance in chronic renal failure (CRF) patients in view of its deleterious link with haemostatic abnormalities [1] and accelerated atherosclerosis [2]. Elevated blood levels of some EC-derived substances are established markers of endothelial activation and/or injury in various disorders [2], including CRF itself [3]. However, plasma levels of these molecules could vary depending on reduced glomerular filtration rate and increased permeability of the glomeruli. Associations between circulating EC markers and progression of renal failure and proteinuria have been the main interest of our study.

We measured the plasma concentrations of soluble thrombomodulin (sTM), antigens (Ag) of tissue factor (TF) and of the main TF inhibitor (tissue factor pathway inhibitor, TFPI), as well as . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?